Table 2.
Pathogens Identified by Indication for Dalbavancin
| Indication for Dalbavancin (No. of Bacterial Isolates) |
Pathogena | ||||
|---|---|---|---|---|---|
| Staphylococcus aureus | Coagulase-Negative Staphylococci | Streptococci | Enterococci | Otherb | |
| Bone or joint infection (n = 109) | 67 (61) | 16 (15) | 4 (4) | 8 (7) | 14 (13) |
| Catheter-related bloodstream infection (n = 27) | 12 (44) | 13 (48) | 0 | 2 (7) | 0 |
| Infective endocarditis (n = 19) | 7 (37) | 2 (11) | 6 (32) | 3 (16) | 1 (5) |
| Complicated bacteremia (n = 7) | 7 (100) | 0 | 0 | 0 | 0 |
| Total (N = 162) | 93 (57) | 31 (19) | 10 (6) | 13 (8) | 15 (9) |
Data are presented as No. (%).
aMore than 1 pathogen was identified in 16 cases; thus, the sum of the number of pathogens (n = 162) exceeds the total number of cases (n = 144) included in the review.
bOther pathogens include Corynebacterium striatum, Aerococcus viridans, Aerococcus urinae, Globicatella sp, Micrococcus luteus, and undefined gram-positive anaerobic organisms.